Evolent Health Says We Do Not Believe We Can Meaningfully Reconcile Guidance For Non-GAAP Adjusted EBITDA To Net Income (Loss) Attributable To Common Shareholders
Portfolio Pulse from Benzinga Newsdesk
Evolent Health (EVH) has announced that it does not believe it can meaningfully reconcile guidance for non-GAAP adjusted EBITDA to net income (loss) attributable to common shareholders.
August 04, 2023 | 12:14 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Evolent Health's inability to reconcile guidance for non-GAAP adjusted EBITDA to net income could lead to uncertainty among investors.
Evolent Health's announcement indicates a lack of clarity in their financial reporting, which could lead to uncertainty among investors. This could potentially have a negative impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100